Life Scientist > Lab Technology

London calling for local biotechs

18 February, 2002 by Pete Young

The London Stock Exchange is spruiking for business from Australian biotech companies who want to transmute their intellectual property into financial capital.

The chips are down 'almost' for IBM Blue Gene project

18 February, 2002 by Tanya Hollis

One of IT giant IBM's key researchers was in Australia this week to tout the progress of the company's $US100 million Blue Gene project.

Research and business meet on new Cerylid board

18 February, 2002 by Melissa Trudinger

Cerylid Biosciences has appointed a scientific advisory board made up of big players from the biotech and pharmaceutical sectors.

Optiscan strikes 'company-making' deal with Pentax

18 February, 2002 by Tanya Hollis

Optiscan Imaging's flexible confocal microscope technology is to be developed and commercialised by marketed by Asahi Optical in a $20 million deal.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd